SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,891.50 14.41
(0.03%)

Dow Jones

7,684.38 -93.79
(-1.21%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.51 -0.31
(-0.33%)

EUR-INR

106.10 -0.35
(-0.33%)

GBP-INR

126.51 -0.13
(-0.10%)

JPY-INR

0.60 0.00
(-0.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bio Medica Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

95758

INE1BKA01015

58.5232566

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BMLL

194.91

EPS(TTM)

Face Value()

Div & Yield %

Back

asian paints ltd

UltraTech Cement consolidated net profit rises 21.29% in the September 2026 quarter

Oct 19,2026

Net profit of UltraTech Cement rose 21.29% to Rs 1493.77 crore in the quarter ended September 2026 as against Rs 1231.58 crore during the previous quarter ended September 2025. Sales rose 18.81% to Rs 23295.07 crore in the quarter ended September 2026 as against Rs 19606.93 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	23295.07	19606.93	19
OPM %	15.97	15.75	-
PBDT	3278.22	2803.51	17
PBT	2064.87	1655.83	25
NP	1493.77	1231.58	21

73,123.83 -125.56 ( -0.17%)

52,891.50 14.41 (0.03%)

7,684.38 -93.79 (-1.21%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.51 -0.31 (-0.33%)

106.10 -0.35 (-0.33%)

126.51 -0.13 (-0.10%)

0.60 0.00 (-0.28%)